The Inflation Reduction Act includes many provisions that aim to reduce out-of-pocket spending for prescription drugs covered under Medicare Part D. In 2024, cost-sharing in the final phase of the Part D benefit, the catastrophic coverage phase, was eliminated.
Age, Gender & Gender Identities
Reports
Displaying 1 - 10 of 1032. 10 per page. Page 1.
Advanced SearchReport to Congress
Children's Interagency Coordinating Council (CICC) FY 2024 Report to Congress
Congress has directed HHS to operate the Children’s Interagency Coordinating Council (CICC). The CICC is charged with fostering greater coordination and transparency on child policy across federal agencies and examining a broad array of cross-cutting issues affecting child poverty and child well-being.
Research Brief
Prevalence and Characteristics of Children Entering Foster Care to Receive Behavioral Health or Disability Services
Custody relinquishment occurs when children enter foster care primarily to receive behavioral health or disability services, not because of maltreatment. Parents may relinquish custody for a variety of reasons. Entering foster care could provide children with access to services that are otherwise unavailable due to limited capacity.
ASPE Issue Brief
Behavioral Health Service Use Among Medicaid and CHIP Enrollees Before/During the COVID-19 Public Health Emergency
In 2020, 53 million adults in the United States had a mental health condition and 40 million people ages 12 and older had a substance use disorder (SUD). The COVID-19 public health emergency (PHE) exacerbated mental health conditions and SUDs at a time when access to in-person care was restricted due to safety concerns.
ASPE Issue Brief
Treatment for Children and Adolescents Enrolled in Medicaid and CHIP During COVID-19
The first brief below provides insight into children’s and adolescents’ mental health service use in Medicaid and CHIP during the pandemic, by using a national Medicaid claims database.
ASPE Issue Brief, Report
An Evaluation Framework for the Inflation Reduction Act’s Medicare Prescription Drug Related Provisions
The Inflation Reduction Act (IRA) changes the way Medicare pays for prescription drugs. These changes will impact various stakeholders, including Medicare, Medicare enrollees, drug manufacturers, and others.
Report
Estimating the Effects of the Medicare $2 Drug List on Part D Enrollees
The Centers for Medicare & Medicaid Services (CMS) Innovation Center is in the process of developing the Medicare $2 Drug List (M2DL) Model. This would allow Part D plan sponsors to offer a standardized list of generic drugs for a copayment of $2 or less for a month’s supply that would not be subject to prior authorization, quantity limits, or other utilization management restrictions.
ASPE Issue Brief
Use of Medicare-Covered Telerehabilitation for PT/OT/SLP Services during the COVID-19 PHE
This study examined the extent therapist practices and nursing homes adopted telehealth services for physical therapy (PT), occupational therapy (OT), and speech-language pathology (SLP); explored the major challenges and facilitators in adopting telerehabilitation services, and whether these services were effective in addressing patient care and staffing needs during the public health emergenc
Report
Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia
Inpatient psychiatric facilities (IPFs) stabilize patients in a mental health crisis and provide services to patients with serious mental illnesses and those who may cause harm to themselves or others, including people living with dementia who have severe behavioral and psychological symptoms.
ASPE Issue Brief
Innovative 988 Crisis Service Systems for Children, Youth, and People with Disabilities
In 2020, Congress designated the new 988 dialing code to be operated through the existing National Suicide Prevention Lifeline. The 988 Suicide and Crisis Lifeline was established to improve access to immediate support to meet the behavioral health crisis needs in the United States.